RHOD and glioblastoma: Additionally, through the use of a deconvolution method and DEG analysis, this study also identified a gene signature consisting of ACP7, EPPK1, PCDHA8, RHOD, DRC1, ZIC3, and PRLR that are associated with poor prognosis in patients with GBM who were treated with TMZ.